Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 3 of 3 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EDARAVONE | 1件: Edaravone Edaravone | 1件: Edaravone
Edaravone
💬1. EDARAVONE
| - | - | 3件: 2 2, 6, 22 💬
| ||||||||||||||||
| 2 | Edaravone (Radicava®/Radicava ORS®) | 1件: Edaravone Edaravone | 1件: Edaravone
Edaravone
💬2. Edaravone (Radicava®/Radicava ORS®)
| - | - | 1件: 2 2 💬2. Edaravone (Radicava®/Radicava ORS®)
| ||||||||||||||||
| 3 | Scopolamine, atropine, edaravone and dexmedetomidine | 4件: Atropine Atropine,Dexmedetomidine, Edaravone, Scopolamine | 4件: Atropine
Atropine
,Scopolamine , Dexmedetomidine , Edaravone 💬 3. Scopolamine, atropine, edaravone and dexmedetomidine
| 8件: ADRA2A ADRA2A,ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 3. Scopolamine, atropine, edaravone and dexmedetomidine | 14件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insu ... | 1件: 2 2 💬3. Scopolamine, atropine, edaravone and dexmedetomidine
|